William Roberts, VP Regulatory Development and at REGENERON PHARMACEUTICALS INC (REGN), sold 12,390 shares at $57.47 ($711K) on 2011-07-13, disclosed to the SEC on 2011-07-13.
Scheduled sale ($711k) by VP Regulatory Development and under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.48 | 2,677 | $154K | 21.6% |
| 2 | $58.37 | 1,388 | $81K | 11.4% |
| 3 | $59.06 | 64 | $4K | 0.5% |
| 4 | $56.67 | 1,339 | $76K | 10.7% |
| 5 | $57.55 | 2,600 | $150K | 21.0% |
| 6 | $56.71 | 1,740 |
| $99K |
| 13.9% |
| 7 | $57.47 | 2,582 | $148K | 20.9% |
| Total | $57.40 avg | 12,390 | $711K | 100% |
| Filing → |
| REGN | SELL | 2012-08-27 | $2.2M | — | Filing → |
| REGN | SELL | 2012-01-11 | $2.4M | — | Filing → |
| REGN | SELL | 2011-09-08 | $1.5M | — | Filing → |